Similar to our findings, a recent meta-analysis comprising 349 critically ill and 337 non-critically ill patients described significantly higher rates of VCAM-1 levels in COVID-19 patients with a proposed cut-off point of 2523.7 ng/ml for critically ill and 1921.1 ng/ml for non-critically ill patients, respectively (21). Here, VCAM1 is linked to COVID-19.